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Device infection is one of the most feared complications in
patients implanted with a cardiac device.1,2 In some cases,
conventional transvenous reimplantation cannot be per-
formed, so alternative approaches are needed.3,4
Case report
A 67-year-old man with dilated cardiomyopathy (New York
Heart Association [NYHA] class III and left bundle branch
block) was implanted with a cardiac resynchronization
therapy and deﬁbrillation (CRT-D) device and was a good
responder (NYHA class I and increase in left ventricular
ejection fraction [LVEF] from 30% to 45%).5 After 2
episodes of device infection and 2 CRT-D extractions, a
new device was required. As superior venous access was no
longer available (thrombosis on 1 side, recent infection on
the other), an epicardial approach was used.6
The whole procedure was minimally invasive and roboti-
cally guided by the da Vinci Robotic System (Intuitive
Surgical Inc, Sunnyvale, CA).7,8 The patient was tilted to the
right side, in order to get more intrathoracic space to facilitate
left ventricle (LV) access (Figure 1). The patient was
intubated with a double-lumen endotracheal Clarins device
for single and right selected lung ventilation (left lung
exclusion), mandatory to access the LV epicardium. The
left chest was insufﬂated, allowing the introduction of a
binocular camera and instruments via 3 transthoracic ports of
10 mm diameter in the anterior axillary line (the ﬁfth
intercostal space for the camera, the third and seventh forKEYWORDS Cardiac resynchronization therapy and deﬁbrillation; Heart
failure; Lead endocarditis; Epicardial lead; Robotic approach
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controlled by the surgeon. The entire LV free wall was
exposed. The leads were introduced through the superior port
and the instruments were placed in the intrathoracic space
through the 2 dedicated ports. This allowed manipulation
and placement of the epicardial leads. The 2 LV leads
(custom-made Medtronic 9022 leads; Medtronic Inc, Min-
neapolis, MN) were placed at the lateral LV wall and ﬁxed at
the pericardium without suture (like a button of a shirt),
after achieving correct sensing/pacing thresholds (o1.5 V at
0.4 ms) (Figure 2). The leads were consequently outside the
pericardial space but the active and steroid-eluding part of
the leads was in close contact with the myocardium. It was
possible to use more readily available steroid-eluting epi-
cardial leads (Medtronic 4968; Medtronic Inc) with the da
Vinci system but sutures are required for lead ﬁxation.
A deﬁbrillation coil was sutured onto the pericardium along
the lateral LV wall, and another was introduced through a
small pericardial incision over the anterior right ventricular
wall (Transvene Medtronic leads), into the pericardial space
(Figure 3). The atrial lead was placed at the right atrial
appendage (again without ﬁxation to the myocardium). All
leads were tunneled to an epigastric device pocket and
connected to the CRT device. A pleural drain was placed
in the left pleural space at the end of the procedure and
removed after 4 hours, as no persistent bleeding was present.
Hospital discharge was possible after 4 days.
The 20 J deﬁbrillation test was successfully performed 3
months after implantation. At 2 years, the patient was a
responder to CRT (NYHA class I, LVEF 45%, brain
natriuretic peptide 73 pg/mL), without signs of recurrent
infection. Sensing and pacing thresholds were stable (1.25 V/
0.4 ms for 1 LV lead and 0.5 V/0.4 ms for the other one, 0.9
mV atrial sensing with 99% ventricular pacing).
Surgical implantation of epicardial LV leads has been
shown to be feasible, with good electrical stability.9 It can be
performed by a left thoracotomy. However, with this
invasive approach, the area of exposed LV is limited for a
CRT-D implant, and even worse with a mini-thoracotomy.10
Alternatively, sternotomy allows unlimited choice of
epicardial pacing site since the entire LV is exposed.pen access article under the CC BY-NC-ND license
http://dx.doi.org/10.1016/j.hrcr.2015.06.008
KEY TEACHING POINTS
 In some cases, conventional transvenous cardiac
resynchronization therapy and deﬁbrillation
(CRT-D) implantation cannot be performed, so
alternative approaches are needed. Thus, surgical
epicardial implantation is mandatory.
 We used a minimally invasive procedure for a
complete epicardial CRT reimplantation in a patient
without superior venous access available. The
whole procedure was robotically guided by the da
Vinci Robotic System.
 This robotic CRT-D implantation was safe and
minimally invasive, with signiﬁcant advantages in
the absence of transvenous access. It offers a new
alternative when conventional approaches are not
suitable.
357Amraoui et al First CRT by Robotic ApproachHowever, this is a complicated, invasive approach with a low
acceptance for patients and longer hospitalization. In centersFigure 1 Da Vinci Robotic System for cardiac resynchronization therapy and d
was tilted to the right side. The binocular camera and instruments were introduced
robotic arms. D: Robotic arms could be controlled remotely at distance by the surwith the robotic system, guided LV lead implantation seems
to be an alternative allowing epicardial CRT-D implantation
with a minimally invasive approach and shorter hospitali-
zation.Discussion
This robotic CRT-D implantation was safe and minimally
invasive, with signiﬁcant advantages in the absence of
transvenous access: no sternotomy, no thoracotomy, no
intravascular material, optimal shock vectors, LV implanta-
tion not dependent on coronary sinus anatomy, short
hospitalization, and lack of any requirement for radiograph
ﬂuoroscopy. Furthermore, this technique minimizes the
difﬁculties of possible future cardiac interventions as no
material is sutured onto the myocardium: the whole system is
placed on the pericardium except for the anterior right
ventricular shock electrode (today, this electrode is placed
outside the pericardial space in the retrosternal fat). This
epicardial device implantation offers a new alternative when
conventional approaches are not suitable.eﬁbrillation implantation: a minimally invasive approach. A, B: The patient
via 3 transthoracic ports of 10 mm diameter. C: Instruments were held by 3
geon.
Figure 3 Chest radiograph of the patient with a cardiac resynchronization therapy and deﬁbrillation (CRT-D) device implanted by robotic approach.
A: Posteroanterior view; B: lateral view: 2 epicardial custom-made Medtronic 9022 left ventricular leads (arrows) were placed at the lateral wall and tunneled to
an epigastric CRT-D device. A right atrial lead and 2 deﬁbrillation coils were tunneled to a CRT-D device localized in the subgastric area. ANT¼ anterior; LL¼
left lateral; RA ¼ right atrium.
Figure 2 Left ventricular (LV) lead implantation. A: Three small pericardial incisions were performed at the left lateral wall with the 2 dedicated instruments
to place the ﬁrst LV lead. B: Each bipolar lead (custom-made Medtronic 9022 leads) has 2 circles at the extremity (asterisks) carrying an active and steroid-
eluting electrode (arrow). C: Each circle of the lead is held by the instruments. D: Each circle of the lead is introduced through 2 pericardial incisions and then
ﬁxed at the pericardium without suture (like a button of a shirt). E: This method allows good contact of the electrode to the LV myocardium without the use of a
needle. F: The second circle at the extremity of the lead is also ﬁxed in the same way.
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